No records
|
55944492500 |
Dicky Levenus Tahapary |
Dr. dr. Dicky Levenus Tahapary, Sp.P.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis |
Lazarus G., Audrey J., Wangsaputra V.K., Tamara A., Tahapary D.L. |
Diabetes Research and Clinical Practice |
1 |
Q1 |
|
|
55944492500 |
Dicky Levenus Tahapary |
Dr. dr. Dicky Levenus Tahapary, Sp.P.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting |
Alkaff F.F., Illavi F., Salamah S., Setiyawati W., Ramadhani R., Purwantini E., Tahapary D.L. |
Journal of Primary Care and Community Health |
|
Q1 |
|
|
No records
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Performance of ldbio aspergillus wb and ict antibody detection in chronic pulmonary aspergillosis |
Rozaliyani A., Setianingrum F., Azahra S., Abdullah A., Fatril A.E., Rosianawati H., Burhan E., Handayani D., Arifin A.R., Zaini J., Tugiran M., Adawiyah R., Syam R., Wibowo H., Wahyuningsih R., Kosmidis C., Denning D.W. |
Journal of Fungi |
|
Q1 |
|
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study |
Surendra H., Elyazar I.R., Djaafara B.A., Ekawati L.L., Saraswati K., Adrian V., Widyastuti, Oktavia D., Salama N., Lina R.N., Andrianto A., Lestari K.D., Burhan E., Shankar A.H., Thwaites G., Baird J.K., Hamers R.L. |
The Lancet Regional Health - Western Pacific |
|
#N/A |
|
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
A living WHO guideline on drugs to prevent covid-19 |
Lamontagne F., Agoritsas T., Siemieniuk R., Rochwerg B., Bartoszko J., Askie L., MacDonald H., Amin W., Bausch F.J., Burhan E., Cecconi M., Chanda D., Dat V.Q., Du B., Geduld H., Gee P., Nerina H., Hashimi M., Hunt B.J., Kabra S., Kanda S., Kawano-Dourado L., Kim Y.-J., Kissoon N., Kwizera A., Leo Y.-S., Mahaka I., Manai H., Mino G., Nsutebu E., Pshenichnaya N., Qadir N., Ranganathan S.S., Sabzwari S., Sarin R., Sharland M., Shen Y., Souza J.P., Stegemann M., Ugarte S., Venkatapuram S., Vuyiseka D., Preller J., Brignardello-Petersen R., Kum E., Qasim A., Zeraatkar D., Owen A., Guyatt G., Lytvyn L., Diaz J., Vandvik P.O., Jacobs M. |
The BMJ |
5 |
Q1 |
|
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
The use of Urinary Lipoarabinomannan (LAM) as a Rapid Diagnostic Test for Adult Pulmonary Tuberculosis in HIV-Positive Patients: An Evidence-based Case Report |
Kusumawardani A., Yanfaunnas A.M., Supandi D.P., Inggita R.A.M., Andayani N.G.A.A.P.T., Louisa M., Soetikno V., Burhan E. |
Journal of International Dental and Medical Research |
|
Q3 |
|
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Diagnostic predictors of active tuberculosis infection in diabetic patients with latent tuberculosis: A review on cathelicidin and 1,25-dihydroxyvitamin d3 |
Arliny Y., Yunus F., Burhan E., Andarini S., Jusman S.W.A., Yunir E., Kekalih A., Soeroton A.Y., Nurwidya F. |
Journal of Natural Science, Biology and Medicine |
|
Q3 |
|
|
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Characteristics and outcomes of endobronchial tuberculosis therapy |
Aniwidyaningsih W., Elhidsi M., Sari A., Burhan E. |
Lung India |
|
Q3 |
|
|